QQ客服 官方微博 反馈留言

	CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic target.
	Gao, Jia-Hui; Yu, Xiao-Hua; Tang, Chao-Ke*
刊名	Clinica chimica acta ; international journal of clinical chemistry
	2019
卷号	495页码:538-544
关键词	Atherosclerosis CXCL12 CXCR4 CXCR7
ISSN号	0009-8981
DOI	10.1016/j.cca.2019.05.022
URL标识	查看原文
WOS记录号	WOS:000476964200080
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5681376
专题	南华大学
作者单位	1.[Tang, Chao-Ke 2.Yu, Xiao-Hua 3.Gao, Jia-Hui] Univ South China, Inst Cardiovasc Dis, Key Lab Atherosclerol Hunan Prov, Med Res Expt Ctr,Hunan Prov Cooperat Innovat Ctr, Hengyang 421001, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Gao, Jia-Hui,Yu, Xiao-Hua,Tang, Chao-Ke*. CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic target.[J]. Clinica chimica acta, international journal of clinical chemistry,2019,495:538-544.
APA	Gao, Jia-Hui,Yu, Xiao-Hua,&Tang, Chao-Ke*.(2019).CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic target..Clinica chimica acta,495,538-544.
MLA	Gao, Jia-Hui,et al."CXC chemokine ligand 12 (CXCL12) in atherosclerosis: An underlying therapeutic target.".Clinica chimica acta 495(2019):538-544.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。